Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care—A Brief Overview and Meta-Analysis of Proportions

por Constantinescu, Catalin, Moisoiu, Vlad, Tigu, Bogdan, Kegyes, David, Tomuleasa, Ciprian
Publicado 2023

Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?

por Kegyes, David, Constantinescu, Catalin, Vrancken, Louise, Rasche, Leo, Gregoire, Celine, Tigu, Bogdan, Gulei, Diana, Dima, Delia, Tanase, Alina, Einsele, Hermann, Ciurea, Stefan, Tomuleasa, Ciprian, Caers, Jo
Publicado 2022

An integrative model of cardiometabolic traits identifies two types of metabolic syndrome

por Frishberg, Amit, van den Munckhof, Inge, ter Horst, Rob, Schraa, Kiki, Joosten, Leo AB, Rutten, Joost HW, Iancu, Adrian C, Dregoesc, Ioana M, Tigu, Bogdan A, Netea, Mihai G, Riksen, Niels P, Gat-Viks, Irit
Publicado 2021

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy

por Iluta, Sabina, Pasca, Sergiu, Gafencu, Grigore, Jurj, Ancuta, Terec, Andreea, Teodorescu, Patric, Selicean, Cristina, Jitaru, Ciprian, Preda, Alexandra, Cenariu, Diana, Constantinescu, Catalin, Iordache, Maria, Tigu, Bogdan, Munteanu, Raluca, Feder, Richard, Dima, Delia, Zdrenghea, Mihnea, Gulei, Diana, Ciuleanu, Tudor‐Eliade, Tomuleasa, Ciprian
Publicado 2021